Make your money go further for just 25p per day

PREMIUM
AIM IHT

Benefit from the boom in healthcare Artificial Intelligence (updated)

AI imagery

This Artificial Intelligence data analytics company, with considerable expertise in neuroscience, had been growing fast over recent years and, following recent share price falls, now looks cracking value. Our in-depth commentary here highlights its appeal in a sector which is predicted to grow significantly over the coming years. The order book offers plenty of visibility and this fascinating business is certainly worth a close look. News of encouraging results from a drug being developed for Alzheimers disease is positive. (IHT qualifying)


IXICO (LON:IXI) is an Artificial Intelligence (‘AI’) data analytics company delivering intelligent insights in neuroscience. Its purpose is to advance medicine and human health in neuroscience by converting raw clinical trial data into clinically meaningful information.


Through the deployment of novel Artificial Intelligence (‘AI’) algorithms, IXICO analyses and interprets brain scans and wearable biosensor data to enable better trial design, patient selection and ultimately better clinical outcomes across all phases of clinical evaluation.

The Group is a…

Continue reading our content…

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • Unlimited access to our market-beating portfolios
  • In-depth coverage of many of the world’s great companies
  • Unique insights from our top research team
Register FREE for access to limited content.
  • Company and markets insights
  • Sponsored content
  • Podcasts

Previous article Next article

Have your say

Log in or register to view or add comments.

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on IXICO PLC

Benefit from the boom in healthcare Artificial Intelligence (updated)

23/05/2023 · Company Insights

This Artificial Intelligence data analytics company, with considerable expertise in neuroscience, had been growing fast over…


Where a 7% dividend yield hides a multitude of issues

04/08/2022 · Company Insights

Updates covered here include a trading update from an unusual provider of alternative finance solutions, which comes…


More Company Insights

A tale of two fund managers

Compelling value | AI appeal

Valuation difficulties

Sign-up to our free email updates

SIGN UP